silybin has been researched along with Osteosarcoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheung, KSC; Leung, F; Liu, ZL; Lu, WW; Sun, T | 1 |
| Bollati-Fogolín, M; Di Virgilio, AL; Etcheverry, SB; Leon, IE; Naso, LG; Porro, V; Williams, PA | 1 |
| Chen, PN; Chu, SC; Hsieh, YS; Liu, YC; Lu, KH; Yang, SF | 1 |
3 other study(ies) available for silybin and Osteosarcoma
| Article | Year |
|---|---|
Matrix metallopeptidase 9 targeted by hsa-miR-494 promotes silybin-inhibited osteosarcoma.
Topics: Apoptosis; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Core Binding Factor Alpha 1 Subunit; Gene Expression Regulation, Neoplastic; Humans; Matrix Metalloproteinase 9; MicroRNAs; Osteosarcoma; Silybin; Silymarin; Up-Regulation | 2018 |
Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Humans; Osteosarcoma; Silybin; Silymarin; Vanadates | 2014 |
Silibinin suppresses human osteosarcoma MG-63 cell invasion by inhibiting the ERK-dependent c-Jun/AP-1 induction of MMP-2.
Topics: Bone Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Shape; Cell Survival; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Focal Adhesion Kinase 1; Humans; Male; Matrix Metalloproteinase 2; Neoplasm Invasiveness; Osteosarcoma; Proto-Oncogene Proteins c-jun; Signal Transduction; Silybin; Silymarin; Transcription Factor AP-1; Urokinase-Type Plasminogen Activator | 2007 |